Morbidly obese (MO) patients with associated restrictive airway disease, obstructive sleep apnea, and coronary artery disease pose challenge to an anesthesiologist. Regional block combined with general anesthesia (GA) is the anesthetic technique of choice as it will decrease the requirement of opioids, anesthetics, and postoperative respiratory depression. A MO patient for modified radical mastectomy was successfully managed with single-injection thoracic paravertebral block and conventional GA.
INTRODUCTION
Morbidly Obese patient pose challenge to the anesthesiologist regarding difficult airway,delayed recovery and need for postoperative assisted ventilation. We present anesthesia management of morbidly obese patient for radical mastectomy performed under thoracic paravertebral block as adjuvant to General anaesthesia successfully.
CASE REPORT
A 53-year-old female, weight 140 kg, height 168 cm, body mass index (BMI) 49.60 kg/m 2 , was posted for left modified radical mastectomy.
Preoperative evaluation revealed that her weight gain was dietary in origin. The patient was hypertensive for 10 years receiving tablet Amtas E 1OD. She gave no history suggestive of obstructive sleep apnea (OSA), coronary artery disease (CAD), diabetes mellitus (DM), thyroid dysfunction. The patient had no contraindication to paravertebral block (PVB) as local sepsis, allergy to local anesthetics, coagulopathy, or severe respiratory disease.
On general examination, her pulse rate was 96/min, blood pressure (BP) was 160/104 mmHg, airway evaluation revealed Mallampati Grade II, and neck circumference was 42.5 cm. Residual stress and cardiovascular (CVS) examination were normal.
Routine hematological, biochemistry investigations including thyroid function test were within normal limits. X-ray of the chest and electrocardiogram (ECG) were normal. Two-dimensional echocardiography showed left ventricular ejection fraction -61%, no regional wall motion abnormality, and LV diastolic dysfunction Grade I. Pulmonary function test was suggestive of moderate restrictive pulmonary function. Arterial blood gas (ABG) on room air revealed This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com ranitidine 150 mg were given 1 h before the surgery. No oral benzodiazepines were given.
In the operation theater, her heart rate was 76/min, BP was 143/81 mmHg, intravenous (IV) access gained with 18-gauge cannula on the nonoperative arm.
Monitoring included 5-lead ECG, noninvasive blood pressure (large-sized cuff), SpO 2 , end-tidal CO 2 (ETCO 2 ), spirometry, peripheral nervous system (ulnar nerve) using Datex Ohmeda monitor.
In sitting position, ipsilateral left PVB was given at T3 level 3 cm lateral from the cephalad edge of spinal process; the skin, subcutaneous tissue, and periosteum of the transverse process (TP) were anesthetized with 2.5 ml of lidocaine 10 mg/ml. Initially, TP was identified with 21-gauge hypodermic needle as shown in Figure 1 and distance to reach TP was noted; then, the PVB was performed with 22-gauge spinal needle, seeking contact with the lateral process of the T3 vertebrae as a landmark before advancing the needle caudally few millimeters into the paravertebral space using loss of resistance technique [ Figure 2 ]; bupivacaine 0.2 ml/kg lean body weight (1 ml = 5 mg) was injected into the paravertebral space in small aliquots with repeated aspiration tests. Paravertebral space was located at a depth of 4.7 cm. T1-T6 dermatome block was achieved in 15 min, demonstrated with decreased sensation to pinprick. No complication such as intrapleural block or pneumothorax was encountered. For optimization of intubating position, sheets were kept below both the scapulae. The patient was preoxygenated with 100% oxygen for 3 min. Induction was achieved with midazolam 1 mg, fentanyl 1 μg/kg, propofol 1 mg/kg, atracurium 0.5 mg/kg. The trachea was intubated nasally with prewarmed Portex endotracheal tube (ETT) (ID 7.0 mm) in the first attempt, tube placement confirmed with capnography, and laryngoscopy revealed Cormack-Lehane Grade II.
Anesthesia was maintained with O 2 /N 2 O 40%-60%, sevoflurane 1.5%-2%, intermittent positive pressure ventilation (IPPV), volume-controlled mode with tidal volume 6-8 ml/kg/min, respiratory rate 11/min, positive end-expiratory pressure (PEEP) 8 cm H 2 O. Maximum paw reached was 32 mmHg. ETCO 2 was maintained between 30 and 34 mmHg, SpO 2 ranged 95%-97%. During the surgery, the patient was hemodynamically stable. Duration of surgery was 150 min. At the end of surgery, neuromuscular block was reversed with IV neostigmine 3.5 mg and glycopyrrolate 0.5 mg.
Emergence was smooth with the patient awake, breathing adequate tidal volume spontaneously, and pain-free. She was shifted to the postanesthesia care unit, nasal ETT in situ, receiving oxygen through T-piece. The trachea was extubated after 16 h. The patient had uneventful recovery.
Postoperative analgesia was managed with preoperative PVB injection diclofenac sodium 75 mg/8 hourly and IV morphine 3 mg as per the requirement if pain score was more than 3. Total morphine required in 24 h was 6 mg.
DISCUSSION
Morbid obesity (MO) is defined as BMI >31 kg/m 2 . MO is associated with CVS and respiratory comorbidities such as CAD, restrictive airway disease, DM, and atherosclerosis. These patients have higher incidence of difficult tracheal intubation; the expiratory reserve volume and functional residual capacity (FRC) are reduced 60%-80%. Anesthesia concerns in MO patients are rapid desaturation during induction of anesthesia as FRC is decreased due to restricted diaphragmatic excursions. A high Mallampati score and large neck circumference increase the risk of difficult laryngoscopy and tracheal intubation. [2] Airway assessment of our patient revealed Mallampati Grade II optimization of intubating position was achieved by keeping sheets below both the scapulae and preoxygenation with 100% oxygen for 3 min was performed to prevent desaturation during induction. Mask ventilation was not difficult.
Nasotracheal intubation was achieved successfully in the first attempt with Macintosh laryngoscope (difficult airway cart was kept available). Nasal ETT was placed as it is better tolerated by the patient postoperatively to maintain airway patency in view of OSA.
Intraoperatively, maintenance of anesthesia was achieved with O 2 /N 2 O sevoflurane minimum alveolar concentration 2%, intermittent bolus of fentanyl, and atracurium. Short-acting agents were preferred to achieve rapid emergence. IPPV with tidal volume was 8-10 ml/min and PEEP 8 cm H 2 O. ETCO 2 was maintained between 30 and 34 mmHg, and paw was between 26 and 32 mmHg. Application of PEEP during induction and before the development of atelectasis improves oxygenation in MO patients. [2] Successful single shot thoracic PVB (TPVB) significantly decreased opioid requirement of our patient during surgery, thus decreasing postoperative respiratory depression; hence, use of short-acting opioids and regional techniques is desirable.
Regional technique
Single-injection TPVB at T3 or T4 is appropriate for mastectomy [3] with a 22-gauge spinal needle , Anatomical landmark method and loss of resistance technique was used to identify paravertebral space .Single injection TPVB was given at T3 for mastectomy surgery with 22 G spinal needle, and 0.2 ml/kg 0.5% bupivacaine was injected. T2-T6 dermatome block was achieved. [4] During the surgery, requirement of opioids was considerably decreased, and total IV 4.5 mg morphine and 80 μg fentanyl were required.
Postoperative pain was managed with TPVB and nonsteroidal anti-inflammatory drug. It has been reported that patients receiving single-injection PVB at T3 with bupivacaine 1.5 mg/ kg require 40% less IV opioids in the postoperative period and incidence of postoperative nausea and vomiting is also decreased. There is evidence of vertical spread of the paravertebrally injected local anesthetic over several adjacent dermatomes. Cheema et al. noted a unilateral spread of sensory analgesia from one to eight dermatomes after a single injection of 15 ml 0.5% bupivacaine for TPVB. [5] Advantages of PVB are easy to perform and analgesia is intense and prolonged, less risk of neurological complications, and profound hypotension because of sympathetic block as with central neuraxial blockade. There is less sedation, nausea, and vomiting as requirement of opioids is reduced. [6] Postoperatively, to maintain airway patency, nasal ETT was retained at the end of surgery as high suspicion of OSA existed. The patient was breathing spontaneously receiving oxygenation through T-piece. She maintained SpO 2 >95 mmHg. The trachea was extubated after 16 h, and she had an uneventful recovery.
CONCLUSION
Single-injection TPVB as adjuvant to general anesthesia decreases the requirement of perioperative opioids thus ensures rapid emergence from anesthesia and reduced postoperative respiratory depression. [7] PVBs have been shown to reduce chronic pain after breast surgery probably by preventing sensitization of the central nervous system and N-methyl D-aspartate receptor wind up. The meta-analysis found evidence on the efficacy and safety of PVB to provide anesthesia and postoperative analgesia during breast surgery with little adverse events. [8] Hence, we recommend TPVB as adjuvant to general anesthesia for MO patients undergoing breast surgery.
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